Evidence map›Paper›PMID 42534674›Full record

ArticleFrontiers in neuroscience2026

Neural speech encoding in fetal alcohol spectrum disorder: an exploratory study using frequency-following responses.

Sheila Templado, Guillermo Savio, Francisco García-Purriños

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sheila TempladoCatholic University San Antonio of Murcia (UCAM), Murcia, Spain.
Guillermo SavioR&D Department, Intelligent Hearing Systems, Miami, FL, United States.
Francisco García-PurriñosCatholic University San Antonio of Murcia (UCAM), Murcia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fetal alcohol spectrum disorder (FASD) is associated with neurodevelopmental impairments, including listening difficulties not always explained by peripheral hearing loss, suggesting alterations at the level of neural auditory processing. The frequency-following response (FFR) provides an objective measure of neural speech encoding and may offer insight into auditory function in this population. Methods: Twenty-five normal-hearing participants were included: 11 individuals with FASD and 14 controls. Speech-evoked FFRs were recorded using a 160 ms /da/ stimulus at 80 dB SPL with a stimulation rate of 4.35/s. Pitch tracking, stimulus-response correlation, response latency, and signal quality were analyzed using non-parametric statistics. Given the exploratory nature of the study and uncontrolled demographic variables - including a significant age difference between groups - findings should be interpreted as preliminary and hypothesis-generating. Results: Compared to controls, individuals with FASD showed reduced pitch-tracking consistency and lower stimulus-response correlation, with the most robust finding being a large-effect reduction in F0-range correlation (R[70-120 Hz]: Conclusion: This exploratory proof-of-concept study provides preliminary evidence of altered neural speech encoding in individuals with FASD despite normal peripheral hearing. Given uncontrolled confounds, observed differences cannot be specifically attributed to FASD. These findings establish the feasibility of FFR in this population and provide the empirical foundation for future controlled research on auditory biomarkers and intervention monitoring in FASD.

Indexed as

auditory processingFASDfetal alcohol spectrum disordersFFRfrequency-following responses

Identifiers

PMID42534674
PMCPMC13422169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.